ID
13434
Descripción
Antibiotic-associated diarrhoea (AAD) is a frequent condition in hospitalised patients receiving antibiotic treatment. The same is true for Clostridium difficile-associated diarrhoea (CDAD) with even more grave consequences of increased morbidity and mortality. The development and evaluation of preventive strategies is one key public health challenge. In the absence of clinically evaluated alternatives, probiotics have been suggested to be beneficial for the prevention of AAD and CDAD. However, data have so far been inconclusive and recently published meta-analyses strongly recommended large state-of-the-art clinical trials on probiotic substances for the prevention of AAD and CDAD. Since the efficacy, side-effects and modes of action of different probiotic bacteria and yeast are strain specific, benefits and risks cannot be generalised. The non-pathogenic yeast Saccharomyces cerevisiae var. boulardii (Sac. boulardii) is considered the most promising probiotic substance for the prevention of AAD and CDAD. We carry out a randomised, placebo controlled, double blind multicentre clinical trial to evaluate Sac. boulardii for the indication of prevention of AAD and CDAD in 1520 adult, hospitalised patients.
Palabras clave
Versiones (2)
- 9/2/16 9/2/16 -
- 11/2/16 11/2/16 -
Subido en
11 de febrero de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
SacBo PZ: Case Report Form Hospitalization Documentation Diarrhea - AAD - CDAD DRKS00000084 NCT01143272
SacBo PZ: Case Report Form Hospitalization Documentation Diarrhea - AAD - CDAD NCT01143272
Descripción
Clinical diagnosis
Descripción
Bloody stool
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0018932
Descripción
Abdominal pain/cramp
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0000737
- UMLS CUI [2]
- C0000729
Descripción
Dehydration
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0011175
Descripción
Fever
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C0015967
Descripción
Medication
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0013227
Descripción
Conservative or surgical therapy for AAD/CDAD
Descripción
Further therapy for AAD/CDAD. (Antibiotics should only be documented as "medication subject to documentation")
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0578159
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [2,1]
- C0235952
- UMLS CUI [2,2]
- C0087111
Descripción
If there was further treatment necessary please specify: (1 treatment per line)
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0578159
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [2,1]
- C0235952
- UMLS CUI [2,2]
- C0087111
Descripción
Further episode of diarrhea/AAD/CDAD
Descripción
Further episode of diarrhea/AAD/CDAD or further stool sample acquired? According to the study protocol there must be at least 5 days without any symptoms between 2 episodes of diarrhea.
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0011991
- UMLS CUI [2]
- C0578159
- UMLS CUI [3]
- C0235952
Similar models
SacBo PZ: Case Report Form Hospitalization Documentation Diarrhea - AAD - CDAD NCT01143272
C0578159 (UMLS CUI [2])
C0235952 (UMLS CUI [3])
C0011008 (UMLS CUI [1,2])
C0430414 (UMLS CUI [2])
C0014245 (UMLS CUI [2])
C0026376 (UMLS CUI [2])
C0000729 (UMLS CUI [2])
C0087111 (UMLS CUI [1,2])
C0235952 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0087111 (UMLS CUI [1,2])
C0235952 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0578159 (UMLS CUI [2])
C0235952 (UMLS CUI [3])